WHERE TO FIND US THIS AUTUMN
Autumn is here! ‘tis the conference season.
The Vitaccess team is excited to share new findings of its digital studies in Melanoma and rare diseases Charcot-Marie-Tooth and Beta-Thalassemia.
We’re looking forward to presenting a short- course at ISPOR Europe on Saturday 2 November in the afternoon. Register here to attend.
We have had 10 abstracts approved and will be presenting the resulting posters at the conferences below.
Come and say hello at our poster presentations to discover more about our patient-centric studies.
Please note: all times are in local time
16-19 October - Austin, Texas
Thursday, 17 October: 1300-1330 and 1530-1600
83: Treatment of Charcot–Marie–Tooth disease in the United Kingdom and United States: insights from a digital real-world observational study
Friday, 18 October: 1300-1330 and 1530-1600
200: Diversity in the Charcot–Marie–Tooth disease population in the United Kingdom and United States: insights from a digital real-world observational study
20-23 October – San Diego, California
Monday 21 October 2019: 15:20 - 16:00
1036: Challenges in localization of patient-reported outcomes instruments destined for smartphone applications
Wednesday 23 October 2019: 15:25 - 16:05
3024: The patient’s voice. Innovation in the localization methodology of real-world evidence ‘Bring Your Own Device’ smartphone apps for quality of life observational studies
If you can’t attend our short course or our poster presentations, we’ll be at booth C2-025 where we’ll demo our study apps.
Saturday, 2 November: 13:00-17:00
Short-course presentation by Dr Mark Larkin, Jon Spinage and Dr Annabel Nixon
Digital real-world evidence generation approaches in rare diseases and oncology
Monday, 4 November: 15:30-18:00
PCN265: Targeted review of adverse events associated with treatments for stage 3 and 4 Melanoma
Wednesday, 6 November: 09:30-14:00
PRO37: Healthcare resource use in Charcot-Marie-Tooth disease in the EU and US: interim results from an international digital real-world study
PRO93: Demographics and treatment patterns for Charcot-Marie-Tooth disease in the EU and US: interim results from an international digital real-world study
PRO116: Understanding the role of real-world evidence in Health Technology Assessment for orphan drugs
PRO136: Patient-reported burden of transfusion-dependent Beta-Thalassemia in the USA and UK measured using a digital app
PRO138: Productivity losses in people with Charcot-Marie-Tooth disease in the EU and US: interim results from an international digital real-world evidence study